N-piperidine Ibrutinib hydrochloride (Compound 1) 是一种可逆的 Ibrutinib 衍生物，N-piperidine Ibrutinib hydrochloride 是一种有效的 BTK 抑制剂，对 WT BTK 和 C481S BTK 的 IC50 值分别为 51.0 和 30.7 nM。N-piperidine Ibrutinib hydrochloride 可作为 BTK 配体，用于合成一系列 PROTAC 分子，如 SJF620 。SJF620 是一种 PROTAC BTK 降解剂，DC50 为 7.9 nM。
货号:ajcx33360
CAS:2231747-18-3
分子式:C22H23ClN6O
分子量：422.91
溶解度:DMSO : 100 mg/mL (236.46 mM; Need ultrasonic)
纯度：98%
存储：Store at -20°C
库存： 现货

Background:

N-piperidine Ibrutinib hydrochloride (Compound 1) is a reversible Ibrutinib derivative. N-piperidine Ibrutinib hydrochloride is a potent BTK inhibitor with IC50s of 51.0 and 30.7 nM for WT BTK and C481S BTK, respectively[1]. N-piperidine Ibrutinib hydrochloride can be used as a BTK ligand in the synthesis of a series of PROTACs, such as SJF620 . SJF620 is a potent PROTAC BTK degrader with a DC50 of 7.9 nM[2].

N-piperidine Ibrutinib hydrochloride can be used as a BTK ligand in the synthesis of a series of PROTACs. SJF638, SJF678, and SJF608 are potent PROTAC BTK degraders with DC50s of 374, 162, and 8.3 nM, respectively[2].

[1]. Buhimschi AD, et al. Targeting the C481S Ibrutinib-Resistance Mutation in Bruton’s Tyrosine Kinase Using PROTAC-Mediated Degradation. Biochemistry. 2018 Jul 3;57(26):3564-3575. [2]. Jaime-Figueroa S, et al. Design, synthesis and biological evaluation of Proteolysis Targeting Chimeras (PROTACs) as a BTK degraders with improved pharmacokinetic properties. Bioorg Med Chem Lett. 2020 Feb 1;30(3):126877.